CN

Chinyya Narasayya Dumplwar

Active Director Director DIN 10266764
DIN 10266764 First appointment Feb 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Chinyya Narasayya Dumplwar

Data last updated:

Chinyya Narasayya Dumplwar is a Director at Amrit Life Science Private Limited (since 2024). The company operates in Pharma.

DIN 10266764
Primary Designation Director
Industry Pharma
First Appointment 22 Feb 2024
Oldest Company Age 16 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Amrit Life Science Private Limited U24100MH2010PTC206325
Director22 Feb 20242010Active

Board colleagues of Chinyya Narasayya Dumplwar

Directorship timeline

Open interactive timeline →
Amrit Life Science Private Limited
Premium access

Shareholding and investment profile for Chinyya Narasayya Dumplwar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chinyya Narasayya Dumplwar

Chinyya Narasayya Dumplwar currently holds 1 directorship: Amrit Life Science Private Limited (Director, since 22 Feb 2024).

Chinyya Narasayya Dumplwar was first appointed on 22 Feb 2024 as Director at Amrit Life Science Private Limited.

The current boards of Chinyya Narasayya Dumplwar's companies include Jayendra Yogendrapal Barara (Amrit Life Science Private Limited), Nitin Premraj Agale (Amrit Life Science Private Limited), Pankaj Surendrapal Barara (Amrit Life Science Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available